These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7426166)

  • 1. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
    Ward DE; Camm AJ; Spurrell RA
    Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Waleffe A; Bruninx P; Kulbertus HE
    J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action and adverse effects of amiodarone in Wolff-Parkinson-White syndrome].
    Cosma C; Crepin D; Py J
    Nouv Presse Med; 1979 Mar; 8(11):865. PubMed ID: 450659
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.
    Rosenbaum MB; Chiale PA; Ryba D; Elizari MV
    Am J Cardiol; 1974 Aug; 34(2):215-23. PubMed ID: 4843156
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous amiodarone in the therapy of paroxysmal supraventricular tachycardias].
    Storelli A; Andriulo C; Chisena A; De Giorgi M; De Giorgio NA; Gallone V; Guadalupi M; Lupis O; Nadovezza S; Tarentini A
    G Ital Cardiol; 1985 Mar; 15(3):290-7. PubMed ID: 4018468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The control of the atrio-ventricular reciprocating tachyarrhythmias. A preliminary electrophysiological study and comparison between amiodarone and verapamil (author's transl)].
    Gronda M; Rognoni G; Rossi P
    G Ital Cardiol; 1978; 8(8):868-78. PubMed ID: 700299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome].
    Vitale P; De Stefano R; Auricchio A
    G Ital Cardiol; 1986 Nov; 16(11):969-74. PubMed ID: 3556935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of Cordarone].
    Preobrazhenskiĭ DV; Ryndina MG; Blizniak GV
    Kardiologiia; 1979 Apr; 19(4):107-12. PubMed ID: 35642
    [No Abstract]   [Full Text] [Related]  

  • 15. Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
    Shahar E; Barzilay Z; Frand M; Feigl A
    Pediatrics; 1983 Dec; 72(6):813-6. PubMed ID: 6646922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
    Depelchin P; Schoenfeld P; Stoupel E; Degré S
    Rev Med Brux; 1986 Feb; 7(2):92-103. PubMed ID: 3515481
    [No Abstract]   [Full Text] [Related]  

  • 17. Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
    Sheinman BD; Evans T
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):999-1000. PubMed ID: 6812745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of experience with amiodarone.
    Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
    Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation complicating Wolff-Parkinson-White syndrome treated with amiodarone.
    Chamberlain DA; Clark AN
    Br Med J; 1977 Dec; 2(6101):1519-20. PubMed ID: 589311
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.